Free Submission Public Relations & NewsPR-inside.com
Home
Deutsch English

Health

Recent Study: SK Biopharmaceuticals Co., Ltd. - Pharmaceuticals & Healthcare - Deals and Alliances Profile


Print article Print article
2014-03-21 19:44:04 - New Pharmaceuticals market report from GlobalData: "SK Biopharmaceuticals Co., Ltd. - Pharmaceuticals & Healthcare - Deals and Alliances Profile"

SK Biopharmaceuticals Co., Ltd. (SK Biopharmaceuticals) is a pharmaceutical company engaged in the development of innovative drugs in central nervous system (CNS) and metabolic disorders. The company undertakes new drug development business and custom manufacturing service (CMS) business to produce pharmaceutical intermediates. It has several investigational new drug (IND) approvals and drugs in both clinical and preclinical development stages. It pipeline products are YKP509, YKP3089, SKL-NP, SKL-N05, YKP509, SKL-DEP, YKP-GI, SKL-PD, and SKL-PSY. It is focused on CNS disorders such as epilepsy, anxiety, depression, schizophrenia, pain, Parkison's disease, irritable bowel, and syndrome; and metabolic disorders such as diabetes. The company forms strategic alliances with major pharmaceutical companies, government institute, foreign investment fund, research network with universities, technical cooperation with biotech,

and investment in biotech. SK CMS is the pharma chemical business division of the company. This division offers process development and optimization; clinical and commercial active pharmaceutical ingredient (API) and intermediate manufacturing; analytical method development and validation; process validation and qualification; CMC and regulatory support; and drug master files (DMF) Filing. SK Biopharmaceuticals operates through a research and development (R&D) center in South Korea; SK Life Science Inc. in the US; and SK Bio-Pharm Tech Co., Ltd. in Shanghai, China. The company is a spun off from SK holdings Life Science Business, which is a third largest conglomerate in south korea. SK Biopharmaceuticals is headquartered in Jongro-gu, Seoul, South Korea.

Full Report Details at
- www.fastmr.com/prod/774620_sk_biopharmaceuticals_co_ltd_pharmace ..

SK Biopharmaceuticals intends to become a top tier specialty pharmaceutical company with global new drugs and innovative pipeline in CNS/metabolic disorders as well as provide world class specialized pharmaceutical manufacturing services by 2020.

SK Biopharmaceuticals Co., Ltd. - Pharmaceuticals & Healthcare - Deals and Alliances Profile provides you comprehensive data and trend analysis of the company's Mergers and Acquisitions (M&As), partnerships and financings. The report provides detailed information on Mergers and Acquisitions, Equity/Debt Offerings, Private Equity, Venture Financing and Partnership transactions recorded by the company over a five year period. The report offers detailed comparative data on the number of deals and their value categorized into deal types, sub-sector and regions.

GlobalData derived the data presented in this report from proprietary in-house Pharma eTrack deals database, and primary and secondary research.

Scope

* Financial Deals - Analysis of the company's financial deals including Mergers and Acquisitions, Equity/Debt Offerings, Private Equity, Venture Financing and Partnerships.
* Deals by Year - Chart and table displaying information encompassing the number of deals and value reported by the company by year, for a five year period.
* Deals by Type - Chart and table depicting information including the number of deals and value reported by the company by type such as Mergers and Acquisitions, Equity/Debt Offering etc.
* Deals by Region - Chart and table presenting information on the number of deals and value reported by the company by region, which includes North America, Europe, Asia Pacific, the Middle East and Africa and South and Central America.
* Deals by Sub-sector - Chart and table showing information on the number of deals and value reported by the company, by sub-sector.
* Major Deals - Information on the company's major financial deals. Each such deal has a brief summary, deal type, deal rationale; and deal financials and target Company's (major public companies) key financial metrics and ratios.
* Business Description - A brief description of the company's operations.
* Key Employees - A list of the key executives of the company.
* Important Locations and Subsidiaries - A list and contact details of key centers of operation and subsidiaries of the company.
* Key Competitors - A list of the key competitors of the company.
* Key Recent Developments - A brief on recent news about the company.

Reasons to Get this Report

Get detailed information on the company's financial deals that enable you to understand the company's expansion/divestiture and fund requirements

* The profile enables you to analyze the company's financial deals by region, by year, by business segments and by type, for a five year period.

Understand the company's business segments' expansion / divestiture strategy

* The profile presents deals from the company's core business segments' perspective to help you understand its corporate strategy.

Access elaborate information on the company's recent financial deals that enable you to understand the key deals which have shaped the company

* Detailed information on major recent deals includes a summary of each deal, deal type, deal rationale, deal financials and Target Company's key financial metrics and ratios.

Equip yourself with detailed information about the company's operations to identify potential customers and suppliers.

* The profile analyzes the company's business structure, locations and subsidiaries, key executives and key competitors.

Stay up-to-date on the major developments affecting the company

* Recent developments concerning the company presented in the profile help you track important events.

Gain key insights into the company for academic or business research

About GlobalData

GlobalData is a leading provider of global business intelligence including market, competitor, product and customer information. It provides in-depth research, analysis, data and forecasts through a range of interactive online databases, reports and management briefings. GlobalData has a large team of experienced research and analysis, consulting, and marketing experts. It has a global presence, including key offices in the US, Europe and Asia. The group has over 50 years of experience of delivering market intelligence data and analysis and a highly experienced senior management team. View more research from GlobalData at www.fastmr.com/catalog/publishers.aspx?pubid=1015

About Fast Market Research

Fast Market Research is a leading distributor of market research and business information. Representing the world's top research publishers and analysts, we provide quick and easy access to the best competitive intelligence available. Our unbiased, expert staff is always available to help you find the right research to fit your requirements and your budget.

For more information about these or related research reports, please visit our website at www.fastmr.com or call us at 1.800.844.8156.


Author:
Bill Thompson
e-mail
Web: www.fastmr.com
Phone: 18008448156

Disclaimer: If you have any questions regarding information in these press releases please contact the company added in the press release. Please do not contact pr-inside. We will not be able to assist you. PR-inside disclaims contents contained in this release.
Latest News
Read the Latest News
www.newsenvoy.com

 


Terms & Conditions | Privacy | About us | Contact PR-inside.com